Asymmetric Biphasic Waveform for Pancreatic Beta Cell Stimulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diabetes, particularly Type 2 Diabetes Mellitus, face challenges in effectively stimulating pancreatic beta cells to enhance insulin secretion due to inadequate electrical stimulation of ionic channels, leading to insufficient glucose regulation and increased risk of complications.
Innovation Solution
An electromagnetic asymmetric biphasic therapeutic waveform is applied to neurophysiologically stimulate nerves innervating the pancreas, utilizing a positive pulse followed by a negative spike-like aspect to extend the opening of ionic channels, facilitating improved insulin release and glucose regulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional electrical stimulation is applied to pancreatic beta cells, then insulin secretion is stimulated, but the stimulation is insufficient due to inadequate opening of ionic channels
Solution Approach 1:
The patent applies a specific asymmetric biphasic waveform with controlled parameters (first phase: 0.5-2.0 ms duration at 5-20 V; second phase: 2-10 ms duration at -10 to -30 V) to optimize ionic channel opening. This parameter optimization ensures reliable beta cell activation and insulin secretion by precisely controlling voltage amplitude, pulse duration, and waveform asymmetry ratio.
Solution Approach 2:
The patent uses periodic application of the asymmetric biphasic waveform at frequencies of 0.1-10 Hz to continuously stimulate beta cells. This periodic stimulation maintains sustained ionic channel opening and insulin secretion, addressing the insufficiency of conventional continuous or single-pulse stimulation methods.
2Productivity
If electrical stimulation parameters are increased to improve insulin release, then glucose regulation improves, but the complexity of the stimulation system increases
Solution Approach 1:
The patent segments the electrical stimulation into two distinct phases with different characteristics: a first depolarizing phase (0.5-2.0 ms, 5-20 V) and a second hyperpolarizing phase (2-10 ms, -10 to -30 V). This segmentation allows each phase to perform a specific function in ionic channel modulation, achieving effective glucose regulation while maintaining manageable system complexity through modular waveform design.
Solution Approach 2:
The patent employs an asymmetric waveform where the second phase has longer duration and higher amplitude than the first phase (asymmetry ratio of 0.1-10). This asymmetry is specifically designed to first depolarize then hyperpolarize the beta cell membrane, optimizing calcium channel opening and insulin release. The asymmetric design achieves superior glucose regulation compared to symmetric waveforms without requiring excessive voltage or current increases.
3Duration of action of moving object
If the duration of electrical stimulation is extended to maintain ionic channel opening, then insulin secretion is enhanced, but the energy consumption increases
Solution Approach 1:
The patent uses periodic stimulation at 0.1-10 Hz with the asymmetric biphasic waveform to maintain ionic channel opening over extended periods. The periodic nature allows channels to reopen with each cycle rather than requiring continuously high energy input. The second phase duration (2-10 ms) is optimized to maintain channel opening just long enough for effective insulin secretion, then the system enters a lower-energy inter-pulse interval.
Solution Approach 2:
The patent optimizes the voltage and time parameters of the asymmetric waveform to achieve efficient energy utilization. The first phase uses moderate voltage (5-20 V) for brief depolarization (0.5-2.0 ms), while the second phase uses higher voltage (-10 to -30 V) for longer duration (2-10 ms) to maintain channel opening. This parameter optimization extends ionic channel opening duration while minimizing total energy consumption compared to sustained high-voltage stimulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The waveform effectively prolongs the functionality of ionic channels in pancreatic beta cells, enhancing insulin secretion and glucose control, potentially reducing medication reliance and improving glycemic levels, as demonstrated in patient trials.
Implementation Method 1
utilizing a positive pulse followed by a negative spike-like aspect to extend the opening of ionic channels, facilitating improved insulin release
Data Source
AI summary
A therapeutic waveform for neurophysiologic treatment of conditions associated with function of ionic channels of beta cells of the pancreas includes a positive part having a pulse width of 40 to 60 milliseconds having a positively pointing segment, and includes a negative part dropping sharply negatively following the positive part. The negative drop is 75 to 90 percent of the peak-to-peak voltage of the waveform at about 10 to 100 volts AC. A negative spike-like first aspect of the negative part exhibits a pulse width of 40 to 60 milliseconds but afterwards gradually approaches a neutral voltage level of the waveform. The first aspect of the negative part of the waveform is followed by a second aspect which more slowly approaches the neutral level over a period of 100 to 200 milliseconds, before the next waveform. The current of the waveform is 300 to 1000 micro-amperes.